| Year |
Citation |
Score |
| 2020 |
Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, Zhou W, Bie P, Liu L, Wen T, Han G, Wang M, Liu R, Lu L, Ren Z, ... ... Dai Z, et al. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer. 9: 682-720. PMID 33442540 DOI: 10.1159/000509424 |
0.326 |
|
| 2020 |
Cai JL, Zhu GQ, Du JX, Wang B, Wan JL, Xiao K, Dai Z. Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices. Expert Review of Gastroenterology & Hepatology. PMID 33131341 DOI: 10.1080/17474124.2021.1845142 |
0.324 |
|
| 2020 |
Zhu GQ, Yu L, Zhou YJ, Du JX, Dong SS, Wu YM, Shi YH, Zhou J, Fan J, Dai Z. Genetic Alterations and Transcriptional Expression of mA RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma. Frontiers in Oncology. 10: 900. PMID 32850303 DOI: 10.3389/Fonc.2020.00900 |
0.345 |
|
| 2019 |
Zhou PY, Yang CP, Tang Z, Yi Y, Liu WR, Tian MX, Huang JL, Gan W, Jiang XF, Liu G, Wang H, Tao CY, Fang Y, Qu WF, Zhou C, ... ... Dai Z, et al. Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study. Aging. 11. PMID 31829979 DOI: 10.18632/aging.102513 |
0.326 |
|
| 2019 |
Hu JW, Yang ZF, Li J, Hu B, Luo CB, Zhu K, Dai Z, Cai JB, Zhan H, Hu ZQ, Hu J, Cao Y, Qiu SJ, Zhou J, Fan J, et al. TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 31822388 DOI: 10.1016/J.Dld.2019.10.010 |
0.375 |
|
| 2019 |
Zhu K, Zhan H, Peng Y, Yang L, Gao Q, Jia H, Dai Z, Tang Z, Fan J, Zhou J. Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma. Carcinogenesis. PMID 31535687 DOI: 10.1093/Carcin/Bgz154 |
0.351 |
|
| 2019 |
Zhu K, Peng Y, Hu J, Zhan H, Yang L, Gao Q, Jia H, Luo R, Dai Z, Tang Z, Fan J, Zhou J. Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway. Carcinogenesis. PMID 31498866 DOI: 10.1093/Carcin/Bgz065 |
0.328 |
|
| 2019 |
Zhu GQ, Yang Y, Chen EB, Wang B, Xiao K, Shi SM, Zhou ZJ, Zhou SL, Wang Z, Shi YH, Fan J, Zhou J, Liu TS, Dai Z. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients. Journal of Translational Medicine. 17: 203. PMID 31215439 DOI: 10.1186/S12967-019-1946-8 |
0.374 |
|
| 2019 |
Tian MX, Liu WR, Wang H, Zhou YF, Jin L, Jiang XF, Tao CY, Tang Z, Zhou PY, Fang Y, Qu WF, Ding ZB, Peng YF, Dai Z, Qiu SJ, et al. Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma. Bmc Medicine. 17: 106. PMID 31164128 DOI: 10.1186/S12916-019-1341-6 |
0.339 |
|
| 2019 |
Zhu GQ, Zhou YJ, Qiu LX, Wang B, Yang Y, Liao WT, Luo YH, Shi YH, Zhou J, Fan J, Dai Z. Prognostic alternative mRNA splicing signature in hepatocellular carcinoma: a study based on large-scale sequencing data. Carcinogenesis. PMID 31099827 DOI: 10.1093/Carcin/Bgz073 |
0.364 |
|
| 2019 |
Yang Y, Chen Q, Piao HY, Wang B, Zhu GQ, Chen EB, Xiao K, Zhou ZJ, Shi GM, Shi YH, Wu WZ, Fan J, Zhou J, Dai Z. HNRNPAB-regulated lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma. International Journal of Cancer. PMID 31090062 DOI: 10.1002/Ijc.32409 |
0.344 |
|
| 2019 |
Zhu GQ, Wang K, Wang B, Zhou YJ, Yang Y, Chen EB, Zhou ZJ, Zhou SL, Shi YH, Zhou J, Dai Z. Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization. Cancer Management and Research. 11: 63-79. PMID 30588111 DOI: 10.2147/Cmar.S186150 |
0.333 |
|
| 2018 |
Zhou J, Sun HC, Wang Z, Cong WM, Wang JH, Zeng MS, Yang JM, Bie P, Liu LX, Wen TF, Han GH, Wang MQ, Liu RB, Lu LG, Ren ZG, ... ... Dai Z, et al. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition). Liver Cancer. 7: 235-260. PMID 30319983 DOI: 10.1159/000488035 |
0.356 |
|
| 2017 |
Liu W, Hu J, Zhou K, Chen F, Wang Z, Liao B, Dai Z, Cao Y, Fan J, Zhou J. Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma. Oncotargets and Therapy. 10: 3843-3851. PMID 28814883 DOI: 10.2147/Ott.S140062 |
0.305 |
|
| 2017 |
Zhou ZJ, Wang XY, Xu XY, Hu ZQ, Chen EB, Zhou SL, Wu WZ, Zhou J, Fan J, Dai Z. [High expression of hnRNPAB/Kap1 together promote poor prognosis in HCC]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 25: 452-457. PMID 28763864 DOI: 10.3760/cma.j.issn.1007-3418.2017.06.012 |
0.348 |
|
| 2017 |
Shi S, Chen Q, Ye L, Yin D, Li X, Dai Z, He J. Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy. Oncotarget. PMID 28611283 DOI: 10.18632/oncotarget.18121 |
0.324 |
|
| 2017 |
Li X, Chen Q, Yin D, Shi S, Yu L, Zhou S, Chen E, Zhou Z, Shi Y, Fan J, Zhou J, Dai Z. Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinoma. Oncology Reports. PMID 28498470 DOI: 10.3892/Or.2017.5616 |
0.394 |
|
| 2017 |
Chen EB, Zhou SL, Pang XG, Yin D, Miao PZ, Yang Y, Chen Q, Zhu K, Gao DM, Liu TS, Wang XY, Shi YH, Wu WZ, Zhou J, Zhou ZJ, ... Dai Z, et al. Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma. Oncotarget. PMID 28159931 DOI: 10.18632/oncotarget.14924 |
0.378 |
|
| 2016 |
Jin L, Liu WR, Tian MX, Jiang XF, Wang H, Zhou PY, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Fan J, Shi YH. CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis. Oncotarget. PMID 28042950 DOI: 10.18632/Oncotarget.14095 |
0.372 |
|
| 2016 |
Hu ZQ, Zhou SL, Zhou ZJ, Luo CB, Chen EB, Zhan H, Wang PC, Dai Z, Zhou J, Fan J, Huang XW. Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection. Oncotarget. PMID 27351132 DOI: 10.18632/Oncotarget.10104 |
0.329 |
|
| 2015 |
Liu WR, Jin L, Tian MX, Jiang XF, Yang LX, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. PMID 26206578 DOI: 10.1016/J.Clinre.2015.06.017 |
0.335 |
|
| 2015 |
Liu WR, Tian MX, Yang LX, Lin YL, Jin L, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, He R, Fan J, Shi YH. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma. Oncotarget. 6: 846-61. PMID 25514599 DOI: 10.18632/Oncotarget.2749 |
0.396 |
|
| 2015 |
Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J, Dai Z, Zhou J. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Letters. 358: 124-35. PMID 25462858 DOI: 10.1016/J.Canlet.2014.11.044 |
0.369 |
|
| 2015 |
Fu XT, Dai Z, Song K, Zhang ZJ, Zhou ZJ, Zhou SL, Zhao YM, Xiao YS, Sun QM, Ding ZB, Fan J. Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway. International Journal of Oncology. 46: 587-96. PMID 25405790 DOI: 10.3892/ijo.2014.2761 |
0.336 |
|
| 2015 |
Liu WR, Tian MX, Jin L, Yang LX, Ding ZB, Shen YH, Peng YF, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads. Annals of Surgical Oncology. 22: 843-50. PMID 25269529 DOI: 10.1245/S10434-014-4043-5 |
0.343 |
|
| 2015 |
Shi JY, Yang LX, Wang ZC, Wang LY, Zhou J, Wang XY, Shi GM, Ding ZB, Ke AW, Dai Z, Qiu SJ, Tang QQ, Gao Q, Fan J. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma. The Journal of Pathology. 235: 546-58. PMID 25255875 DOI: 10.1002/Path.4450 |
0.364 |
|
| 2014 |
Dai Z, Zhou SL, Zhou ZJ, Bai DS, Xu XY, Fu XT, Chen Q, Zhao YM, Zhu K, Yu L, Yang GH, Wang Z, Wu WZ, Zhou J, Fan J. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways. The Journal of Pathology. 234: 316-28. PMID 24962955 DOI: 10.1002/Path.4395 |
0.37 |
|
| 2014 |
Liu WR, Tian MX, Jin L, Yang LX, Ding ZB, Shen YH, Peng YF, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research : Cr. 33: 32. PMID 24716838 DOI: 10.1186/1756-9966-33-32 |
0.357 |
|
| 2014 |
Zhou ZJ, Dai Z, Zhou SL, Hu ZQ, Chen Q, Zhao YM, Shi YH, Gao Q, Wu WZ, Qiu SJ, Zhou J, Fan J. HNRNPAB induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating SNAIL. Cancer Research. 74: 2750-62. PMID 24638979 DOI: 10.1158/0008-5472.Can-13-2509 |
0.371 |
|
| 2014 |
Jiang JH, Liu YF, Ke AW, Gu FM, Yu Y, Dai Z, Gao Q, Shi GM, Liao BY, Xie YH, Fan J, Huang XW, Zhou J. Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing. Hepatology (Baltimore, Md.). 59: 2216-27. PMID 24425307 DOI: 10.1002/Hep.27012 |
0.39 |
|
| 2014 |
Dai Z, Zhou J, Fan J. Abstract 4069: Capn4 contributes to tumor growth and metastasis of hepatocellular carcinoma by activation of FAK-Src signaling pathways Cancer Research. 74: 4069-4069. DOI: 10.1158/1538-7445.Am2014-4069 |
0.382 |
|
| 2013 |
Zhu K, Dai Z, Zhou J. Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy. Biomarker Research. 1: 10. PMID 24252133 DOI: 10.1186/2050-7771-1-10 |
0.356 |
|
| 2013 |
Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, Zhou J, Qiu SJ, Dai Z, Fan J. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy. 9: 2056-68. PMID 24157892 DOI: 10.4161/Auto.26398 |
0.354 |
|
| 2013 |
Yan J, Tan C, Gu F, Jiang J, Xu M, Huang X, Dai Z, Wang Z, Fan J, Zhou J. Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase Liver Transplantation. 19: 507-520. PMID 23408515 DOI: 10.1002/Lt.23619 |
0.337 |
|
| 2013 |
Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology (Baltimore, Md.). 56: 2242-54. PMID 22711685 DOI: 10.1002/Hep.25907 |
0.402 |
|
| 2012 |
Zhou ZJ, Dai Z, Zhou SL, Fu XT, Zhao YM, Shi YH, Zhou J, Fan J. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma. International Journal of Cancer. 132: 1080-9. PMID 22821376 DOI: 10.1002/Ijc.27742 |
0.343 |
|
| 2012 |
Zhou S, Tan C, Dai Z, Zhu H, Xu M, Zhou Z, Wang W, Zhao Y, Fu X, Zhou J, Fan J. Tacrolimus enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma: involvement of vascular endothelial growth factor-C. Transplantation Proceedings. 43: 2747-54. PMID 21911157 DOI: 10.1016/j.transproceed.2011.06.040 |
0.349 |
|
| 2011 |
Yu L, Dai Z, Wang Z, Fan J, Zhou J. Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy. Oncology. 116-22. PMID 22212945 DOI: 10.1159/000333273 |
0.38 |
|
| 2011 |
Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, Zhang Z, Lu S, Huang X, Wang Z, Qiu S, Wang X, Yang G, Sun H, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4781-8. PMID 22105822 DOI: 10.1200/Jco.2011.38.2697 |
0.3 |
|
| 2011 |
Hu J, Wang Z, Fan J, Dai Z, He YF, Qiu SJ, Huang XW, Sun J, Xiao YS, Song K, Shi YH, Sun QM, Yang XR, Shi GM, Yu L, et al. Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation. Plos One. 6: e26003. PMID 21998744 DOI: 10.1371/Journal.Pone.0026003 |
0.333 |
|
| 2011 |
Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB, Shi GM, Ke AW, Yang XR, Tao ZH, Zhao YM, Qin Y, Zeng HY, Tang ZY, et al. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7294-302. PMID 21976539 DOI: 10.1158/1078-0432.Ccr-11-1327 |
0.37 |
|
| 2011 |
Ding ZB, Hui B, Shi YH, Zhou J, Peng YF, Gu CY, Yang H, Shi GM, Ke AW, Wang XY, Song K, Dai Z, Shen YH, Fan J. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6229-38. PMID 21825039 DOI: 10.1158/1078-0432.Ccr-11-0816 |
0.368 |
|
| 2011 |
Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke AW, Wang XY, Dai Z, Peng YF, Gu CY, Qiu SJ, Fan J. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy. 7: 1159-72. PMID 21691147 DOI: 10.4161/Auto.7.10.16818 |
0.317 |
|
| 2011 |
Zhao YM, Wang L, Dai Z, Wang DD, Hei ZY, Zhang N, Fu XT, Wang XL, Zhang SC, Qin LX, Tang ZY, Zhou J, Fan J. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma. International Journal of Cancer. Journal International Du Cancer. 129: 2463-72. PMID 21213214 DOI: 10.1002/Ijc.25918 |
0.307 |
|
| 2011 |
Dai Z, Zhou J, Fan J. [Cellular signaling pathways involved in hepatocellular carcinoma occurrence and progression]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 18: 955-7. PMID 21205491 DOI: 10.3760/Cma.J.Issn.1007-3418.2010.12.022 |
0.349 |
|
| 2011 |
Wang DD, Zhao YM, Wang L, Ren G, Wang F, Xia ZG, Wang XL, Zhang T, Pan Q, Dai Z, Chen JP, Dai HY, Zhang W, He HW, Zhou JM, et al. Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection. Journal of Cancer Research and Clinical Oncology. 137: 651-8. PMID 20549233 DOI: 10.1007/S00432-010-0927-3 |
0.362 |
|
| 2010 |
Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Sun J, Tan CJ, Dai Z. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Expert Opinion On Investigational Drugs. 18: 1595-604. PMID 19780708 DOI: 10.1517/13543780903292626 |
0.335 |
|
| 2010 |
Liu S, Huang C, Dai Z, Zhou J, Qiu S, Fan J. Screening of potential serum biomarkers of microvascular invasion in human hepatocellular carcinoma by iTRAQ technology Chinese Journal of Experimental Surgery. 27: 149-152. DOI: 10.3760/Cma.J.Issn.1001-9030.2010.02.005 |
0.34 |
|
| 2009 |
Dai Z, Zhou J, Qiu S, Liu Y, Fan J. Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers. Electrophoresis. 30: 2957-2966. PMID 19711376 DOI: 10.1002/Elps.200900064 |
0.348 |
|
| 2009 |
Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, et al. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery Clinical Cancer Research. 15: 5518-5527. PMID 19706825 DOI: 10.1158/1078-0432.Ccr-09-0151 |
0.305 |
|
| 2009 |
Ding ZB, Shi YH, Zhou J, Shi GM, Ke AW, Qiu SJ, Wang XY, Dai Z, Xu Y, Fan J. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma. Cancer. 115: 4753-65. PMID 19626651 DOI: 10.1002/cncr.24513 |
0.337 |
|
| 2009 |
Bai DS, Dai Z, Zhou J, Liu YK, Qiu SJ, Tan CJ, Shi YH, Huang C, Wang Z, He YF, Fan J. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology (Baltimore, Md.). 49: 460-70. PMID 19053044 DOI: 10.1002/Hep.22638 |
0.399 |
|
| 2008 |
Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, Shi GM, Wang XY, Ke AW, Wu B, Fan J. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Research. 68: 9167-75. PMID 19010888 DOI: 10.1158/0008-5472.Can-08-1573 |
0.39 |
|
| 2008 |
Li Y, Qin X, Cui J, Dai Z, Kang X, Yue H, Zhang Y, Su J, Cao J, Ou C, Yang C, Duan X, Yue H, Liu Y. Proteome analysis of aflatoxin B1-induced hepatocarcinogenesis in tree shrew (Tupaia belangeri chinensis) and functional identification of candidate protein peroxiredoxin II. Proteomics. 8: 1490-501. PMID 18318006 DOI: 10.1002/pmic.200700229 |
0.319 |
|
| 2008 |
Yang G, Dai Z, Zhou J. Advance in proteomic study of hepatocellular carcinoma World Chinese Journal of Digestology. 16: 2487. DOI: 10.11569/WCJD.V16.I22.2487 |
0.341 |
|
| 2007 |
Qiu JG, Fan J, Liu YK, Zhou J, Dai Z, Huang C, Tang ZY. Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 134: 299-305. PMID 17828420 DOI: 10.1007/S00432-007-0236-7 |
0.31 |
|
| 2007 |
Cui J, Kang X, Dai Z, Huang C, Zhou H, Guo K, Li Y, Zhang Y, Sun R, Chen J, Li Y, Tang Z, Uemura T, Liu Y. Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification. Journal of Cancer Research and Clinical Oncology. 133: 825-34. PMID 17516088 DOI: 10.1007/s00432-007-0224-y |
0.309 |
|
| 2006 |
Dai Z, Liu YK, Cui JF, Shen HL, Chen J, Sun RX, Zhang Y, Zhou XW, Yang PY, Tang ZY. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis. Proteomics. 6: 5857-67. PMID 17068759 DOI: 10.1002/Pmic.200500707 |
0.342 |
|
| 2006 |
Cui JF, Liu YK, Zhang LJ, Shen HL, Song HY, Dai Z, Yu YL, Zhang Y, Sun RX, Chen J, Tang ZY, Yang PY. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro. Proteomics. 6: 5953-61. PMID 17051636 DOI: 10.1002/pmic.200500460 |
0.316 |
|
| 2005 |
Song HY, Liu YK, Feng JT, Cui JF, Dai Z, Zhang LJ, Feng JX, Shen HL, Tang ZY. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. Journal of Cancer Research and Clinical Oncology. 132: 92-8. PMID 16261346 DOI: 10.1007/s00432-005-0044-x |
0.35 |
|
| 2005 |
Feng JT, Liu YK, Song HY, Dai Z, Qin LX, Almofti MR, Fang CY, Lu HJ, Yang PY, Tang ZY. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics. 5: 4581-8. PMID 16240287 DOI: 10.1002/Pmic.200401309 |
0.361 |
|
| Show low-probability matches. |